Your browser doesn't support javascript.
loading
Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.
Regan, M M; Walley, B A; Francis, P A; Fleming, G F; Láng, I; Gómez, H L; Colleoni, M; Tondini, C; Pinotti, G; Salim, M; Spazzapan, S; Parmar, V; Ruhstaller, T; Abdi, E A; Gelber, R D; Coates, A S; Goldhirsch, A; Pagani, O.
Affiliation
  • Regan MM; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
  • Walley BA; International Breast Cancer Study Group Statistical Center, Boston, USA.
  • Francis PA; University of Calgary and Canadian Cancer Trials Group, Calgary, Canada.
  • Fleming GF; Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne.
  • Láng I; Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, Melbourne, Australia.
  • Gómez HL; The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, USA.
  • Colleoni M; National Institute of Oncology and International Breast Cancer Study Group, Medical Oncology, Budapest, Hungary.
  • Tondini C; Division of Medicine, Instituto Nacional de Enfermedades Neoplásicas and International Breast Cancer Study Group, Lima, Peru.
  • Pinotti G; Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan.
  • Salim M; Medical Oncology, Ospedale Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo.
  • Spazzapan S; Medical Oncology, ASST Sette Laghi-Ospedale di Circolo and Fondazione Macchi and International Breast Cancer Study Group, Varese, Italy.
  • Parmar V; Allan Blair Cancer Center, Regina, Canada.
  • Ruhstaller T; Medical Oncology, Centro di Riferimento Oncologico and International Breast Cancer Study Group, Aviano, Italy.
  • Abdi EA; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre and International Breast Cancer Study Group, Mumbai, India.
  • Gelber RD; Breast Center St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen.
  • Coates AS; International Breast Cancer Study Group, St. Gallen, Switzerland.
  • Goldhirsch A; Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, The Tweed Hospital, Griffith University Gold Coast, Tweed Heads, Australia.
  • Pagani O; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.
Ann Oncol ; 28(9): 2225-2232, 2017 Sep 01.
Article in En | MEDLINE | ID: mdl-28911092
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Breast Neoplasms / Premenopause / Antineoplastic Agents, Hormonal Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Breast Neoplasms / Premenopause / Antineoplastic Agents, Hormonal Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: